Search results
SonoVascular partners with Lantheus for VTE treatment
Medical Device Network· 1 day ago“Our collaboration with SonoVascular leverages both companies' strengths to help change the paradigm...
CDC identifies first documented cases of HIV transmitted through cosmetic needles
The Telegraph· 5 days agoThe Centers for Disease Control and Prevention said in its Morbidity and Mortality Report last week that an investigation into the clinic ...
GSK raises profit outlook on strong vaccine, HIV drug sales - ET HealthWorld | Pharma
The Economic Times· 3 days agoCEO Emma Walmsley's strategy has focussed on vaccines, cancer and infectious diseases and a shift in...
Brief anger could lead to heart attack: Study
Deseret News· 20 hours agoThe most common negative emotion studied is anger, and there are fewer studies on anxiety and sadness, which have also been linked to heart attack risk.
Traffic noise can increase risk of cardiovascular disease: Study
Business Standard India· 6 days agoSpike in traffic noise can increase the risk of cardiovascular diseases, including heart attack,...
Incorporating Zytee Gel into Your Oral Care Routine
Mid Day· 2 days agoZytee Gel can help manage mouth ulcers and lower discomfort. To maximise the effectiveness of this gel, it's crucial to adhere to proper usage...
All Cattle To Get Compulsory Ear-tags In Nashik Dist | Nashik News - Times of India
The Times of India· 6 days agoNashik: The district administration has decided to block the transportation of cattle unless each cattle is ear-tagged with a unique identity (ID). This initiative is to prevent cattle being ...
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology· 4 days agoThe full approval is based on positive data from the Phase...Tivdak significantly improved overall...
FDA brings lab tests under federal oversight in bid to improve accuracy and safety - ET HealthWorld
The Economic Times· 4 days agoThe goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and...
Bitterroot Bio kickstarts Phase I trial for cardiovascular disease candidate
Clinical Trials Arena· 5 days agoThe study involves healthy participants, who will receive subcutaneous administrations of BRB-002 –...